Tagged: EpiC project

  • Machine learning can help prevent interruption of HIV treatment

    To help reach the UNAIDS 95-95-95 targets by 2025, the public health community must ensure that people living with HIV have access to antiretroviral therapy (ART). Access to this lifesaving medication is one issue; staying on it is another, because continuing ART is not always possible due to a variety of circumstances. In a project FHI 360 recently concluded in Nigeria, we demonstrated how machine learning can complement the efforts of health care workers to help people stay on ART. 

    Continue reading

  • Overcoming challenges to ensure access to medical oxygen

    Medical oxygen is a lifesaving, essential medicine. Access to it is vital for treating patients at all levels of the health system, during both routine and emergency care. The COVID-19 pandemic caused surges in demand for oxygen, resulting in critical shortages, especially in low- and middle-income countries. Even in the absence of a pandemic, health care facilities need medical oxygen to treat newborns, children with severe pneumonia, people with chronic and infectious conditions, and patients requiring surgery.

    Continue reading

  • Fit for purpose: Building on HIV investments for the global health security response

    Twenty years ago, the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) was established to lead the global response to the HIV epidemic. Today, PEPFAR is a public health engine: a critical platform for strengthening health systems, preparing for and responding to pandemics, and enabling global health security. Here, we share how PEPFAR made it possible for FHI 360’s teams to effectively respond to COVID-19 in countries with established HIV infrastructure.

    Continue reading

  • One size doesn’t fit all: Why differentiated services are still needed for the next phase of the HIV response

    Over the past decade, there have been remarkable advances in the HIV prevention, treatment and epidemic control tools used by the global community working to address HIV. Investments in scientific discovery and implementation research have furthered our understanding of the factors driving the epidemic, as well as the biology of viral transmission. Prevention, diagnostic and treatment strategies have improved immensely, as have antiretroviral drugs. 

    Continue reading